A
RMD icon

AustralianSuper’s ResMed RMD Stock Holding History

AustralianSuper’s Portfolio RMD Stock Details RMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$57.8M Sell
296,761
-137,853
-32% -$28.6M 0.25% 91
2026
Q1 		$97.6M Buy
434,614
+25,748
+6% +$6.42M 0.51% 58
2025
Q4 		$98.5M Buy
408,866
+51,381
+14% +$13.1M 0.46% 47
2025
Q3 		$97.9M Buy
357,485
+46,079
+15% +$12.6M 0.46% 51
2025
Q2 		$80.3M Buy
311,406
+41,226
+15% +$9.83M 0.41% 60
2025
Q1 		$60.5M Buy
270,180
+166,257
+160% +$38.8M 0.34% 82
2024
Q4 		$23.8M Buy
103,923
+100,836
+3,266% +$24.3M 0.11% 114
2024
Q3 		$754K Hold
3,087
– – ﹤0.01% 219
2024
Q2 		$591K Buy
+3,087
New +$626K ﹤0.01% 215

Other funds holding RMD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

AustralianSuper's RMD Position: Q2 2026 in Review

AustralianSuper reduced its ResMed (RMD) stake by 32% in Q2 2026, selling an estimated $28.6M and leaving 296,761 shares worth $57.8M. The position accounts for 0.25% of the portfolio, ranked #91.

AustralianSuper first reported a position in RMD in Q2 2024 and has held it in 9 quarters since. The position peaked at $98.5M in Q4 2025. 886 funds tracked by Wall St. Rank hold RMD as of Q2 2026.

  • AustralianSuper held 296,761 shares of ResMed worth $57.8M as of Q2 2026.
  • AustralianSuper sold 137,853 ResMed shares in Q2 2026, an estimated $28.6M.
  • ResMed made up 0.25% of AustralianSuper's portfolio in Q2 2026, its #91 holding.
  • AustralianSuper first reported a position in ResMed in Q2 2024 and has held it in 9 quarters since.
  • AustralianSuper's ResMed position peaked at $98.5M in Q4 2025.
  • 886 funds tracked by Wall St. Rank held ResMed as of Q2 2026.

Based on AustralianSuper's 13F filing for Q2 2026, filed 12 Aug 2026.